Robin Seim Net Worth

The estimated Net Worth of Robin Gene Seim is at least $7.58 Million dollars as of 9 August 2021. Mr. Seim owns over 6,686 units of Omnicell stock worth over $1,294,210 and over the last 19 years he sold OMCL stock worth over $5,891,532. In addition, he makes $396,590 as Director at Omnicell.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Seim OMCL stock SEC Form 4 insiders trading

Robin has made over 52 trades of the Omnicell stock since 2007, according to the Form 4 filled with the SEC. Most recently he sold 6,686 units of OMCL stock worth $1,013,598 on 9 August 2021.

The largest trade he's ever made was exercising 31,124 units of Omnicell stock on 29 March 2010 worth over $247,125. On average, Robin trades about 6,209 units every 58 days since 2006. As of 9 August 2021 he still owns at least 30,049 units of Omnicell stock.

You can see the complete history of Mr. Seim stock trades at the bottom of the page.

Robin Seim biography

Robin Gene Seim is Director of the Company. Mr. Seim has served as a director of Omnicell since March 2019. Mr. Seim initially joined Omnicell in January 2006 and served in various financial and operational leadership roles, including Chief Financial Officer from January 2006 to August 2015 and President, Global Automation and Medication Adherence from March 2016 until his retirement in March 2019. Prior to joining Omnicell, Mr. Seim served as Chief Financial Officer of several technology companies, including Villa Montage Systems, Inc. from 1999 to 2001, Candera, Inc. from 2001 to 2004 and Mirra, Inc., in 2005. Prior to 1999, Mr. Seim held a number of management positions with Nortel Networks, Bay Networks, and IBM. Mr. Seim received a B.S. in accounting from California State University, Sacramento.

What is the salary of Robin Seim?

As the Director of Omnicell, the total compensation of Robin Seim at Omnicell is $396,590. There are 9 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.

How old is Robin Seim?

Robin Seim is 60, he's been the Director of Omnicell since 2019. There are 10 older and 9 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.

What's Robin Seim's mailing address?

Robin's mailing address filed with the SEC is OMNICELL, INC., 4220 NORTH FREEWAY, FORT WORTH, TX, 76137.

Insiders trading at Omnicell

Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps, and Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.

What does Omnicell do?

since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice

Complete history of Mr. Seim stock trades at Omnicell

Omnicell executives and stock owners

Omnicell executives and other stock owners filed with the SEC include:

• Randall Lipps,
  Chairman of the Board, President, Chief Executive Officer
• Peter Kuipers,
  Chief Financial Officer, Executive Vice President
• Scott Seidelmann,
  Executive Vice President and Chief Commercial Officer
• Randall A. Lipps,
  Founder, Exec. Chairman, Pres & CEO
• Nhat Ngo,
  Executive Vice President - Marketing, Strategy and Business Development
• Daniel Johnston,
  Executive Vice President, Chief Legal and Administrative Officer
• Peter J. Kuipers,
  Exec. VP & CFO
• Scott Peter Seidelmann,
  Exec. VP & Chief Commercial Officer
• Christine Mellon,
  Exec. VP, Chief Admin. & People Officer
• Robin Seim,
  Director
• Bruce Scott,
  Independent Director
• James Judson,
  Lead Independent Director
• Joanne Bauer,
  Independent Director
• Mark Parrish,
  Independent Director
• Sara White,
  Independent Director
• Vance Moore,
  Independent Director
• Bruce Smith,
  Independent Director
• Joseph Spears,
  Senior Vice President, Chief Accounting Officer, Corporate Controller
• Jorge R. Taborga,
  Exec. VP of Engineering & Integration Management Officer
• Roxanne Turner,
  VP of Corp. Responsibility & Chief Compliance Officer
• Corey J. Manley,
  Sr. VP & Chief Legal Officer
• Kathleen Nemeth,
  Sr. VP of Investor Relations
• Giri Chodavarapu,
  Sr. VP & Chief Information Officer
• Joseph Brian Spears,
  Sr. VP, Chief Accounting Officer & Corp. Controller
• Gary S Petersmeyer,
  Director
• Jorge R. Taborga,
  Executive VP. Engineering
• J Christopher Drew,
  EVP, Business Development
• Randy D Lindholm,
  Director
• Corey J Manley,
  EVP&CHIEF LEGAL/ADMIN OFFICER
• Nchacha Etta,
  EVP & CFO
• Kaushik Ghoshal,
  
• Marga Ortigas Wedekind,
  Vice President, Marketing
• Donald C Wegmiller,
  Director
• Mary E Foley,
  Director
• William G. Shields,
  Executive Vice President
• Michael D Stevenson,
  Exec. VP, Global Manufacturing
• Joseph E Whitters,
  Director
• William H Jr Younger,
  Director
• Partners Iii Llc Abs,
  10% owner
• Renee M Luhr,
  VP Sales
• Brock Nelson,
  Director
• Brian Robert Rodli,
  Vice President/Marketing
• Charles J Barnett,
  Director
• Benjamin A Horowitz,
  Director
• Timothy T Weglicki,
  10% owner
• John D Jr Stobo,
  Director
• Capital Partners Iii L P Abs,
  10% owner
• John D Higham,
  SVP Marketing
• Kevin L Roberg,
  Director
• John Choma,
  S.V.P. H.R. Emp. Learn & Perf.
• Dennis P Wolf,
  Exec VP, CFO
• Gary E Wright,
  Exec VP Sales
• Donald B Jr Hebb,
  10% owner
• Chusak Siripocanont,
  Sr. VP, Eng., Mfg. & Quality
• Edward Peter Bousa,
  
• Eileen J. Voynick,
  
• Mary Garrett,
  
• Dan S Johnston,
  EVP, EXECUTIVE ADVISOR
• Christine Marie Mellon,
  EVP, EXECUTIVE ADVISOR
• Brian H. Nutt,
  VP, Chief Accounting Officer